
Health authorities are set to expand the clinical and field validation of machine-learning methylation-based models across various regions and medical indications, aiming to ensure data transparency and integrity. This decision comes in response to widespread public health alarms, particularly regarding tobacco and Alzheimer's impact, alongside emerging distrust in research following recent integrity issues. With no technical inconsistencies detected, stakeholders project low risk, reinforcing the need for vigilant monitoring as confidence in predictive genetics grows.

Title not available for this citation.
“Immunohistochemical analysis... showed a significant 2.33-fold (p = 0.0001) higher PDX1 protein expression in the PCa compared to the normal prostate tissues.”

Title not available for this citation.
“Although the etiology of perinatal suicidal ideation (SI) is not well understood, DNA methylation may provide meaningful mechanistic insights and/or serve as clinical biomarkers during the peripartum period.”

Title not available for this citation.
“Post-partum ideation-risk was successfully predicted using the top ten genome-wide differentially methylated probes at 17 weeks (AUC=66.9%).”

Title not available for this citation.
“Our study revealed a significant positive correlation between the overexpression of the ZDHHC24 gene and increased risk of IA. For each one standard deviation increase in ZDHHC24 expression, the risk of IA increases by 21.85%.”

Title not available for this citation.
“Further mediation effect analysis revealed that methylation sites cg01806972, cg10523820, cg18862171, and cg26041493 indirectly influence the occurrence of IA by regulating the expression of the ZDHHC24 gene, with mediation effects accounting for 33.19%, 26.71%, 32.93%, and 47.16% of the total effect, respectively.”